申请人:SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD.
公开号:US11518766B2
公开(公告)日:2022-12-06
A compound represented by formula (I), an optical isomer thereof and a pharmaceutically acceptable salt thereof, as well as an application of said compound as an FXIa inhibitor.
一种由式(I)代表的化合物、其光学异构体和其药学上可接受的盐,以及所述化合物作为 FXIa 抑制剂的应用。